Palvella Therapeutics Inc. (PVLA) Live Share Price, Invest From India

Palvella Therapeutics Inc. Stock Performance

as on June 19, 2026 at 2:15 pm IST

Day's Low
Day's High
$110.96
Day's Price Range
$116.08
$113.10
1.89%
Downside
2.63%
Upside
52 Week's Low
52 Week's High
$20.35
52-Week Price Range
$151.18
$113.10
82.01%
Downside
33.67%
Upside

Palvella Therapeutics Inc. share price movements today

Previous Close: $112.63
Open: $115.70
Volume: 337.1K
Day's Low - High: $110.96 - $116.08
52 Week Low - High: $20.35 - $151.18

Palvella Therapeutics Inc. Historical Returns

1 Month Return: + 3.57 %
3 Month Return: -0.71 %
1 Year Return: + 451.44 %
3 Year Return: 0 %
5 Year Return: 0 %

Palvella Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Palvella Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.6B

EPS (TTM)

-5.5654

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-34.25%

Palvella Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Palvella Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Palvella Therapeutics Inc.	NA	$1.6B	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$37.7B	57.21%	71.21	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$116.5B	140.42%	27.22	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$63.7B	13.39%	14.85	29.65%	0.58%

Stock Returns calculator for Palvella Therapeutics Inc. Stock including INR - Dollar returns

The Palvella Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Palvella Therapeutics Inc. investment value today

Current value as on today

₹5,98,870

Returns

₹4,98,870

(+498.87%)

Returns from Palvella Therapeutics Inc. Stock

₹4,51,438 (+451.44%)

Dollar Impact

₹47,431 (+47.43%)

Indian Investors' Interest in Palvella Therapeutics Inc. Stock

Search interest for Palvella Therapeutics Inc. Stock has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 20, 2026 to June 19, 2026

Change:6% versus previous 30 day period

Palvella Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	1	0	-	-	-	-	-	-	-	-
Gross Profit	1	-	-	-	-	-	-	-	-	-
Operating Income	-5	-1	-2	-5	-4	-7	-9	-10	-11	-14
EBITDA	-4	-1	-3	-1	-2	-6	-8	0	-10	-17
Interest Expense	-	0	1	1	1	1	1	1	1	2
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-4	-2	-4	-6	-3	-8	-9	-11	-12	-15
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-4	-2	-4	-6	-3	-8	-9	-11	-12	-15
Net Profit Margin	-352.89%	-4784.91%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Palvella Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	5	25	29	46	29	31	25	-	-	-
Gross Profit	-	-	-	-	29	29	23	-	-	-
Operating Income	-22	-14	-30	-27	-33	-51	-43	-11	-14	-38
EBITDA	-22	-16	-26	-24	-34	-43	-30	18	-13	-35
Interest Expense	-	-	-	-	-	-	-	-	4	5
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-22	-16	-27	-25	-37	-45	-33	18	-17	-41
Income Tax Expense	0	1	0	-	0	-	-1	-	-	-
Net Income	-22	-17	-26	-25	-37	-45	-33	18	-17	-41
Net Profit Margin	-391.00%	-69.82%	-91.93%	-55.03%	-126.97%	-145.58%	-128.47%	0.00%	0.00%	0.00%

Palvella Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-2	-4	-6	-3	-8	-9	-11	-7	-15
Operating Cash Flow	-1	-1	-2	-5	-6	-5	-7	-4	-10
Investing Cash Flow	-	-	-	-3	-	-	-	-	-55
Financing Cash Flow	-	9	2	74	-1	0	0	0	214
Change in Cash	1	0	0	69	56	-5	-6	-5	148

Palvella Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-45	-27	18	-17	-41
Operating Cash Flow	-7	-14	-13	-10	-25
Investing Cash Flow	0	-21	-	-	-
Financing Cash Flow	59	9	5	87	0
Change in Cash	47	-5	-31	76	-25

Global Institutional Holdings in Palvella Therapeutics Inc.

Funds	Holdings
Vanguard Capital Management, LLC	3.33%
Woodline Partners LP	2.21%
PRIMECAP Management Company	1.36%
Bvf Inc	6.7%
Frontier Capital Management CO Inc	2.61%

See all

Insights on Palvella Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, PVLA has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 1 year, PVLA stock has moved up by 451.4%
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, PVLA has outperformed top 5 stocks with highest market-cap in its industry
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 6 quarters, -3.95M → -15.76M (in $), with an average decrease of 35.8% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 4 quarters, 20.05M → 53.0K (in $), with an average decrease of 64.0% per quarter

About Palvella Therapeutics Inc.

Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product candidate is QTORIN rapamycin, a novel, 3.9% anhydrous topical gel that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of angiokeratomas and other mTOR-driven skin diseases; and QTORIN pitavastatin for the treatment of disseminated superficial actinic porokeratosis. The company is based in Wayne, Pennsylvania.

Organisation	Palvella Therapeutics Inc.
Headquarters	353 W. Lancaster Avenue, Wayne, PA, United States, 19087
Industry	Biotechnology
CEO	Mr. Wesley H. Kaupinen
E-voting on shares	Click here to vote

Key Management of Palvella Therapeutics Inc.

Name	Title
Ms. Sarah Foster	Senior Vice President of Human Resources
Mr. Jason Burdette	SVP of CMC & Technical Operations
Mr. Matthew E. Korenberg	CFO, Corporate Secretary & Treasurer
Dr. Jeffrey Martini Ph.D.	Chief Scientific Officer
Ms. Bohan Wei	Vice President of Corporate Development & New Product Planning
Mr. Kent Taylor	Senior Vice President of Sales
Mr. Wesley H. Kaupinen	Founder, President, CEO & Director
Ms. Kathleen Goin	Chief Operating Officer
Ms. Emily Cook	Senior Vice President of Clinical Operations
Ms. Ashley Hartmann Kline M.B.A.	Chief Commercial Officer

FAQs

What is Palvella Therapeutics Inc. share price today?

Palvella Therapeutics Inc. share price today is $113.1 as on June 19, 2026 at 8:45 am IST at the close of the market. Palvella Therapeutics Inc. share today touched a day high of $116.08 and a low of $110.96.

What is the 52 week high and 52 week low for Palvella Therapeutics Inc. share?

Palvella Therapeutics Inc. share touched a 52 week high of $151.18 on February 26, 2026 and a 52 week low of $20.35 on June 27, 2025. Palvella Therapeutics Inc. stock price today i.e. June 19, 2026 at 8:45 am IST is closed at $113.1,which is 25.19% down from its 52 week high and 455.77% up from its 52 week low.

What is Palvella Therapeutics Inc.'s market capitalisation today?

Palvella Therapeutics Inc. market capitalisation is $0.00T as on June 19, 2026 at 8:45 am IST.

How to invest in Palvella Therapeutics Inc. Stock (PVLA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Palvella Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Palvella Therapeutics Inc. Shares that will get you 0.0133 shares as per Palvella Therapeutics Inc. share price of $113.1 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Palvella Therapeutics Inc. Stock (PVLA) from India?

Indian investors can start investing in Palvella Therapeutics Inc. (PVLA) shares with as little as ₹94.31 or $1 (as of June 19, 2026 at 7:45 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Palvella Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on June 19, 2026 at 7:45 pm IST). Based on Palvella Therapeutics Inc. share’s latest price of $113.1 as on June 19, 2026 at 8:45 am IST, you will get 0.0884 shares of Palvella Therapeutics Inc.. Learn more about fractional shares .